Bio import/export customs brokerage

01Overview and value chain#

Markers EC: Biological/pharmaceutical import-export customs clearance | OECD: Bioeconomy policy & governance | Regulator: FDA (US)

Bio import/export customs brokerage is a B2B logistics services category in which specialist firms clear biological materials, pharmaceuticals, clinical-trial specimens and cell/gene therapies through customs at national borders, combining customs documentation expertise with temperature-controlled shipping and importer-of-record liability management. World Courier (part of Cencora) runs specialist cold-chain and cell/gene-therapy logistics operations, including a recently upgraded facility in Osaka, Japan, expanding its Asia-Pacific footprint. Marken (part of UPS Healthcare) provides precision logistics for pharmaceutical and biotech clients at every development stage, recently strengthening its Asia-Pacific healthcare capabilities to power a connected clinical-to-commercial journey. Kuehne+Nagel operates a “Cool Corridor” network of temperature-controlled logistics lanes for healthcare shipments, expanding both its air-logistics cool-chain coverage and its North American healthcare footprint. Expeditors International participated in the 2026 Global Pharma Supply Chain Summit in Shanghai, reflecting its active pharma-logistics practice spanning US and Chinese trade lanes. DB Schenker runs a dedicated “life+” state-of-the-art warehouse in the Benelux region for pharma and healthcare shipments, addressing the complexities of airfreight-based pharmaceutical logistics. Sinotrans, a major Chinese state-linked logistics group, operates cold-chain and customs-clearance services relevant to biological and pharmaceutical shipments moving through Chinese ports.

The key directions of bio import/export customs brokerage are:

Biological cold-chain customs clearance: coordinating customs documentation and clearance timing with temperature-controlled shipping so a biological shipment does not spend time out of its required temperature range while awaiting customs release.
Importer-of-record (IOR) services: assuming or managing the legal importer-of-record liability for pharmaceutical and biological shipments, a role with significant compliance exposure that many clients prefer to outsource.
Controlled-substance and biological import-permit management: securing the specific import permits required for controlled substances, biological specimens and clinical-trial materials in each destination country.
Clinical-to-commercial logistics continuity: maintaining a single logistics relationship as a biological product moves from clinical-trial-stage shipments through to commercial-scale distribution.

Sectoral value chain#

[Shipment preparation & documentation] ──> [Import-permit securing] ──> [Customs clearance & IOR management]
                                                                    │
                                                        (Cold-chain continuity monitoring)
                                                                    │
              [Last-mile temperature-controlled delivery] <──── [Border release] <─── [Temperature-controlled transport]

Fig. 1— Sectoral value chain

Value chain levels#

Level	Description	Key inputs/outputs
Shipment preparation	Preparing customs documentation, product classification and shipping paperwork specific to the biological material or pharmaceutical product.	In: Product specification, destination-country requirements. Out: Customs documentation package.
Import-permit securing	Obtaining the specific import permits required for controlled substances, biological specimens or clinical materials in the destination country.	In: Customs documentation package. Out: Approved import permit.
Temperature-controlled transport	Moving the shipment via cold-chain logistics that maintain the required temperature range throughout transit.	In: Approved import permit, shipment. Out: In-transit shipment under temperature control.
Customs clearance and IOR management	Clearing the shipment through customs, with the broker often assuming importer-of-record liability on the client’s behalf.	In: In-transit shipment, import permit. Out: Customs-cleared shipment.
Border release	The shipment is formally released from customs custody and can proceed to its final destination.	In: Customs-cleared shipment. Out: Released shipment.
Last-mile temperature-controlled delivery	Completing final delivery to the client site while maintaining the cold-chain temperature range to the point of receipt.	In: Released shipment. Out: Delivered shipment within specification.

Table 1— Value chain levels

Cross-cutting technologies of the sector:

Biological cold-chain customs clearance: the specific practice of coordinating customs timing with temperature-controlled shipping to avoid a temperature excursion during customs hold.
Importer-of-record services: assuming or managing the legal liability of being the importer-of-record for a pharmaceutical or biological shipment.
Controlled-substance import-permit management: securing country-specific import permits for controlled substances, biological specimens and clinical-trial materials.

02US#

The United States hosts major global logistics groups with dedicated life-sciences customs-brokerage and cold-chain practices.

World Courier’s cell/gene-therapy logistics, Marken’s clinical-to-commercial continuity, Expeditors’ active China-lane pharma practice#

World Courier (Cencora): runs specialist cold-chain and cell/gene-therapy logistics operations, including a recently upgraded Osaka, Japan facility expanding its Asia-Pacific footprint.
Marken (UPS Healthcare): provides precision logistics for pharmaceutical and biotech clients at every development stage, recently strengthening its Asia-Pacific healthcare capabilities for a connected clinical-to-commercial journey.
Expeditors International: participated in the 2026 Global Pharma Supply Chain Summit in Shanghai, reflecting an active pharma-logistics practice spanning US and Chinese trade lanes.

03CN#

China hosts major state-linked logistics groups whose cold-chain and customs-clearance operations extend to biological and pharmaceutical shipments moving through Chinese ports.

Sinotrans’ cold-chain and customs-clearance services for biological shipments#

Sinotrans: a major Chinese state-linked logistics group operating cold-chain and customs-clearance services relevant to biological and pharmaceutical shipments moving through Chinese ports.

04EU#

Europe hosts several of the world’s largest freight and logistics groups, each running dedicated pharma and healthcare cold-chain networks with customs expertise built into the service.

Kuehne+Nagel’s Cool Corridor network, DB Schenker’s life+ pharma warehouse#

Kuehne+Nagel: operates a “Cool Corridor” network of temperature-controlled logistics lanes for healthcare shipments, recently expanding both its air-logistics cool-chain coverage and its North American healthcare footprint.
DB Schenker: runs a dedicated “life+” state-of-the-art warehouse in the Benelux region for pharma and healthcare shipments, addressing the complexities of airfreight-based pharmaceutical logistics.

05Leading companies and research institutes#

Company / Institute	Country	Key products / platforms	Tech features	Status 2026
World Courier	🇺🇸 USA	Cold-chain & cell/gene-therapy logistics	Recently expanded Osaka facility	commercial
Marken	🇬🇧 United Kingdom	Precision logistics (UPS Healthcare)	Clinical-to-commercial continuity	commercial
Kuehne+Nagel	🇨🇭 Switzerland	Cool Corridor network	Temperature-controlled healthcare lanes	commercial
Expeditors International	🇺🇸 USA	Pharma logistics & customs brokerage	Active US-China pharma trade lanes	commercial
DB Schenker	🇩🇪 Germany	life+ pharma warehouse network	Airfreight-focused pharma logistics	commercial
Sinotrans	🇨🇳 China	Cold-chain & customs clearance	State-linked, major China port coverage	commercial

Table 2— Leading companies and research institutes

06Tech stack and innovations#

The bio import/export customs brokerage stack combines temperature-controlled logistics infrastructure with specialized customs and importer-of-record expertise:

Biological cold-chain customs clearance:
- Firms such as Kuehne+Nagel’s Cool Corridor network coordinate customs timing with temperature-controlled transit lanes to prevent temperature excursions during customs hold.
Importer-of-record services:
- World Courier and Marken assume or manage importer-of-record liability for pharmaceutical and biological shipments, a significant compliance exposure many clients outsource.
Clinical-to-commercial logistics continuity:
- Marken’s connected clinical-to-commercial network maintains a single logistics relationship as a biological product scales from clinical-trial shipments to commercial distribution.

07Value chains and production pipelines#

Industrial pipeline for a biological shipment’s customs clearance#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Shipment preparation     │ ───> │ 2. Import-permit            │
│    & documentation               │      │    securing                      │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Customs clearance &      │ <─── │ 3. Temperature-controlled   │
│    IOR management                │      │    transport                     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Border release           │ ───> │ 6. Last-mile temperature-   │
│                                  │      │    controlled delivery           │
└───────────────────────────┘      └───────────────────────────┘

Fig. 2— Industrial pipeline for a biological shipment’s customs clearance

Stage 1: Shipment preparation and documentation

The broker prepares customs documentation, product classification and shipping paperwork specific to the biological material or pharmaceutical product.

Stage 2: Import-permit securing

The broker obtains the specific import permits required for controlled substances, biological specimens or clinical materials in the destination country.

Stage 3: Temperature-controlled transport

The shipment moves via cold-chain logistics that maintain the required temperature range throughout transit, ahead of arrival at the destination border.

Stage 4: Customs clearance and importer-of-record management

The shipment clears customs, with the broker often assuming importer-of-record liability on the client’s behalf to manage the associated compliance exposure.

Stage 5: Border release

The shipment is formally released from customs custody and can proceed toward its final destination.

Stage 6: Last-mile temperature-controlled delivery

Final delivery to the client site is completed while maintaining the cold-chain temperature range to the point of receipt.

Supplier	Region & tags
World Courier	US
Marken	EU
Kuehne+Nagel	EU
Expeditors International	US
DB Schenker	EU
Sinotrans	China

AI Recommendation

Key directions:

Biological cold-chain customs clearance — coordinating customs documentation and clearance timing with temperature-controlled shipping so a biological shipment does not spend time out of its required temperature range while awaiting release.
Importer-of-record (IOR) services — assuming or managing the legal importer-of-record liability for pharmaceutical and biological shipments, a role many clients prefer to outsource.
Controlled-substance and biological import-permit management — securing the specific import permits required for controlled substances, biological specimens and clinical-trial materials in each destination country.
Clinical-to-commercial logistics continuity — maintaining a single logistics relationship as a biological product moves from clinical-trial shipments through to commercial-scale distribution.

Regulatory:

Customs authorities in each destination country set their own import-permit and documentation requirements for controlled substances and biological specimens, so a single shipment lane can face very different clearance rules depending on origin and destination.
A temperature excursion during a customs hold can render a biological shipment unusable even after it clears, which is why cold-chain continuity through the customs step (not just during transport) is treated as a distinct discipline.
Importer-of-record status carries direct legal and financial liability for customs compliance, which is why many pharmaceutical and biotech shippers outsource this role to a specialist broker rather than assume it themselves.

Companies not in table: DHL Global Forwarding Life Sciences was searched as a candidate but returned no confirming live source and was excluded rather than tabled from general knowledge; no other confirmed candidate was dropped, since the six-row table filled exactly from the confirmed set with good regional spread (three US, two EU, one China).

Processing note: all six candidates searched for this article confirmed on the first pass, so no second-round retries were needed in any region.

Category boundary: this is distinct from general freight forwarding — the differentiator here is specialist expertise in biological/pharmaceutical customs documentation and cold-chain-aware clearance timing, not simply moving cargo across a border.